wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36448681-3BF7C7AB-4F86-41EC-B07D-B72C85445CB5
Q36448681-3BF7C7AB-4F86-41EC-B07D-B72C85445CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36448681-3BF7C7AB-4F86-41EC-B07D-B72C85445CB5
Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference.
P2860
Q36448681-3BF7C7AB-4F86-41EC-B07D-B72C85445CB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36448681-3BF7C7AB-4F86-41EC-B07D-B72C85445CB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbc593b8b93efb1f5e3292a02a0e0ea5a5828ed5
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.